Table 1 Major published series of patients undergoing surgery for coexisting peritoneal carcinomatosis and liver metastases from colorectal cancer
Author | Year | n (peritoneal + liver/total) | OS (peritoneal + liver/only peritoneal) | Observations |
|---|---|---|---|---|
Kianmanesh et al. | 2007 | 37.2 % (16/43) | 36 vs. 35.3 months | No differences between groups |
Only 70 % of patients having CC-0 or CC-1 surgery | ||||
Chua et al. | 2009 | 29.1 % (16/55) | 65 vs. 68 %, 2 years | No differences between groups |
Group of combined liver and peritoneal, lower PCI (8 vs. 12) | ||||
Varban et al. | 2009 | 9.9 % (14/142) | 23 vs. 15.8 months | No differences between groups |
43.3 vs. 36.8 %, 2 years | Median number and size of liver metastasis: 1 (1–7) and 3 cm (0.4–12) | |||
Elias et al. | 2009 | 14.72 % (77/523) | 21 vs. 27 %, 5 years | Multicentric study |
No differences between groups | ||||
Glehen et al. | 2004 | 12.15 % (61/502) | 16.8 vs. 20.4 months | Liver metastasis as negative predictive factor for OS (p = 0.008) |
Maggiori et al. | 2013 | 37 vs. 60 | 40 vs. 66 %, 3 years | Median OS 40 months for PCI <12 and 1 or 2 liver metastases |
32 vs. 49 months |